Delivery Order SPE2DB20D2014-SPE2DB25FD19F
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,948.05 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $46,287.17. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 3, 2025. AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $63,121.17 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitively awarded procurement. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $48,639.41 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 23, 2025, with completion scheduled for June 24, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of the vendor's pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,386.55 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $7,764.93 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of August 20, 2025. This competitive award, issued on August 19, 2025, carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $31,530.56 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Otezla 30 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 28, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $13,341.78 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count). The contract, executed on June 25, 2025, with an ultimate completion date of June 26, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. This...
- The Defense Logistics Agency awarded a delivery order valued at $35,436.55 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single line item fulfilling pharmaceutical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD19FDelivery Order
The Defense Logistics Agency awarded a $35,178.29 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Otezla 30 mg, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a single delivery order fulfillment of the pharmaceutical product to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen has demonstrated capability to fulfill federal procurement requirements through open competition and maintains a significant presence in the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.2k | 9/29/25 |